Patents by Inventor Brigitte Gicquel

Brigitte Gicquel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6204038
    Abstract: The present invention relates to the isolation of a new gene, des, which encodes a M. tuberculosis protein named DES. The des gene appears to be conserved among different Mycobacteria species. The amino acid sequence of the DES protein contains two sets of motifs that are characteristic of the active sites of enzymes from the class II diiron-oxo protein family. Among this family of proteins, DES shares significant homology with soluble stearoyl-ACP desaturases. DES is a highly antigenic protein, which is recognized by human sera from patients infected with M. tuberculosis and M. leprae but not by sera from tuberculous cattle. Thus, the DES protein provides a useful tool for the serodiagnostic analysis of tuberculosis.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: March 20, 2001
    Assignee: Institut Pasteur
    Inventors: Mary Jackson, Brigitte Gicquel
  • Patent number: 6096549
    Abstract: A process for replacing a nucleotide sequence in the genome of a mycobacterium strain comprises the steps of:a) providing a vector containing SacB gene coding for levane saccharase enzyme and a nucleotide sequence of interest;b) transfecting the mycobacterium strain with the vector;c) selecting clones of the resulting transfected mycobacteria for replacement of the nucleotide sequence of interest by propagating the transfected clones in a culture medium supplemented with sucrose; andd) isolating the recombinant strain.The process is useful for positive selection of allelic exchange mutants, such as in Mycobacterium tuberculosis complex.
    Type: Grant
    Filed: June 11, 1997
    Date of Patent: August 1, 2000
    Assignee: Institut Pasteur
    Inventors: Vladimir Pelicic, Jean-Marc Reyrat, Brigitte Gicquel, Christophe Guilhot, Mary Jackson
  • Patent number: 6010855
    Abstract: The present invention relates to the isolation of a new gene, des, which encodes a M. tuberculosis protein named DES. The des gene appears to be conserved among different Mycobacteria species. The amino acid sequence of the DES protein contains two sets of motifs that are characteristic of the active sites of enzymes from the class II diiron-oxo protein family. Among this family of proteins, DES shares significant homology with soluble stearoyl-ACP desaturases. DES is a highly antigenic protein, which is recognized by human sera from patients infected with M. tuberculosis and M. leprae but not by sera from tuberculous cattle. Thus, the DES protein provides a useful tool for the serodiagnostic analysis of tuberculosis.
    Type: Grant
    Filed: July 25, 1997
    Date of Patent: January 4, 2000
    Assignee: Institut Pasteur
    Inventors: Mary Jackson, Brigitte Gicquel
  • Patent number: 5968815
    Abstract: The invention relates to a nucleotide sequence which is present at a position adjacent to the 5' end of the reverse sequence complementary to the open reading frame coding for a potential transposase contained in the insertion element IS900 in Mycobacterium paratuberculosis. The nucleotide sequence has promoter functions and contains important signals for the regulation of transcription and translation. The invention also relates to methods for cloning and expressing heterologous proteins using such regulatory sequences, to vectors and transformed host cells containing these sequences, and to immunogenic compositions prepared by expression of nucleotide sequences placed under control of these regulatory sequences.
    Type: Grant
    Filed: October 6, 1994
    Date of Patent: October 19, 1999
    Assignees: Institut Pasteur, Massey University
    Inventors: Alan Murray, Marina Gheorghiu, Brigitte Gicquel
  • Patent number: 5877273
    Abstract: The present invention relates to nucleotide sequences of Actinomycetales, in particular of mycobacteria, to oligonucleotides contained within said nucleotide sequences, to their uses as primers for the synthesis of Actinomycetales DNA and as probes for the detection of DNA and/or the transcription products of Actinomycetales, in particular of mycobacteria, to the products of expression of said sequences, to their uses and to antibodies directed towards the said products, to a method for detecting and identifying Actinomycetales and its uses, as well as to immunogenic compositions comprising the said expression products.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 2, 1999
    Assignee: Institut National de la Sante et de la Recherche Mediale-Inserm & Institute Pasteur
    Inventors: Allan Johnson Hance, Bernard Grandchamp-Desraux, Veronique Levy-Frebault, Brigitte Gicquel
  • Patent number: 5843664
    Abstract: A process for replacing a nucleotide sequence in the genome of a mycobacterium strain comprises the steps of:a) providing a vector containing SacB gene coding for levane saccharase enzyme and a nucleotide sequence of interest;b) transfecting the mycobacterium strain with the vector;c) selecting clones of the resulting transfected mycobacteria for replacement of the nucleotide sequence of interest by propagating the transfected clones in a culture medium supplemented with sucrose; andd) isolating the recombinant strain.The process is useful for positive selection of allelic exchange mutants, such as in Mycobacterium tuberculosis complex.
    Type: Grant
    Filed: June 11, 1996
    Date of Patent: December 1, 1998
    Assignee: Institut Pasteur
    Inventors: Vladimir Pelicic, Jean-Marc Reyrat, Brigitte Gicquel
  • Patent number: 5837455
    Abstract: Fragments of nucleic acids derived from an appropriate mycobacteria genome, particularly Mycobacterium tuberculosis, their applications in the diagnosis of mycobacteria infections, as well as plasmides containing said fragments. The nucleotidic sequence is comprised of a nucleotidic sequence repeated in the genome of a mycobacterium and specific of the bacillus of tuberculosis and is characterized by a strong hybridation with M. tuberculosis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 17, 1998
    Assignee: Institut Pasteur
    Inventors: Jean-Luc Guesdon, Dominique Thierry, Agnes Ullmann, Brigitte Gicquel, Anne Brisson-Noel
  • Patent number: 5830457
    Abstract: The present invention relates to a nucleotide sequence characterized in that it is selected amongst the following nucleotide sequences: the sequence of the gene coding for a B-lactamase, or any part of said gene, particularly the sequence between nucleotides 1 and 394 containing the signals for expression of the gene, or the coding sequence comprising nucleotides 395 to 1274, or any sequence hybridizing under stringent conditions with the above sequence. Utilization of B-lactamase as a carrier protein for carrying heterolog epitopes for the preparation of vaccine compositions is also disclosed.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: November 3, 1998
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Juliano Timm, Joaquim Trias, Colette Duez, Maria-Grazia Perilli, Jean Dusart, Jean-Marie Frere
  • Patent number: 5817459
    Abstract: The present invention relates to nucleotide sequences of Actinomycetales, in particular of mycobacteria, to oligonucleotides contained within said nucleotide sequences, to their uses as primers for the synthesis of Actinomycetales DNA and as probes for the detection of DNA and/or the transcription products of Actinomycetales, in particular of mycobacteria, to the products of expression of said sequences, to their uses and to antibodies directed towards the said products, to a method for detecting and identifying Actinomycetales and its uses, as well as to immunogenic compositions comprising the said expression products.
    Type: Grant
    Filed: February 11, 1991
    Date of Patent: October 6, 1998
    Assignees: Institut National de la Sante et de la Recherche Mediale-Inserm, Institute Pasteur
    Inventors: Allan Johnson Hance, Bernard Grandchamp-Desraux, Veronique Levy-Frebault, Brigitte Gicquel
  • Patent number: 5807672
    Abstract: Fragments of nucleic acids derived from an appropriate mycobacteria genome, particularly Mycobacterium tuberculosis, their applications in the diagnosis of mycobacteria infections, as well as plasmides containing said fragments. The nucleotidic sequence is comprised of a nucleotidic sequence repeated in the genome of a mycobacterium and specific of the bacillus of tuberculosis and is characterized by a strong hybridation with M. tuberculosis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 15, 1998
    Assignee: Institut Pasteur
    Inventors: Jean-Luc Guesdon, Dominique Thierry, Agnes Ullman, Brigitte Gicquel, Anne Brisson-Noel
  • Patent number: 5597911
    Abstract: Nucleic acid fragments have been obtained from the genome of mycobacteria, and applications of the nucleic acid fragments in the diagnosis of mycobacterial infections are described. More particularly, the present invention concerns an isolated polynucleotide of the formula:5'-(SEQ ID NO: 1)-(formula III)-(SEQ ID NO: 2)-3'where formula III represents a polynucleotide containing nucleotides 343-1152 of SEQ ID NO: 3. Primers and probes based on the isolated polynucleotide, DNA complementary to any of the polynucleotides, primers or probes, a method of detecting and identifying at least one species or group of mycobacteria, and a kit, box, or coordinated set for conducting the method are also described.
    Type: Grant
    Filed: April 14, 1992
    Date of Patent: January 28, 1997
    Assignee: Institut Pasteur
    Inventors: Jean-Luc Guesdon, Dominique Thierry, Agn es Ullmann, Brigitte Gicquel, Anne Brisson-Noel